Revenue

Artificial intelligence demands unprecedented, volatile power. Now, a new battle is on to define and build the 'AI-grade' infrastructure needed to fuel it.

Beyond the DKK 302M contract, the Solbakken project in Odense showcases Denmark's innovative, self-funded strategy for social and green infrastructure.

A new partnership eliminates the need for parallel AI infrastructure, embedding a secure, self-service AI layer directly onto existing Kubernetes platforms.

The Canada Revenue Agency's 'Manage balance' service has processed $1.1B in debt, but does this digital shift truly help all Canadians?

MorningBlues' new SonicGlass A1 isn't just a speaker; it's a transparent art piece that generates AI music videos. Is this the future of home audio?

Spurred by national policy and landmark listings, Japan's innovators are looking to U.S. capital markets for global growth. A new summit maps the path.

GCL's deal for 'A Whisper of Fall: Jinyiwei' isn't just another game. It's a strategic move capitalizing on the global hunger for authentic Asian IP.

As institutional capital seeks refuge from market volatility, Stable Asset Management's $100M backing of Zenzic Capital signals a major bet on specialist credit.

A public company is offering a volatile mix of OpenAI, Worldcoin, and MrBeast. We deconstruct the high-risk, high-reward strategy behind its unique treasury.

The appointment of Bethany Sensenig, a veteran of PE-backed turnarounds, signals CenExel is preparing for a major push to dominate the clinical research market.

Utah's Co-Diagnostics is transferring its AI-powered diagnostic platform to a Saudi JV. It's a bold move to crack a booming market and a critical test of its strategy.

Intelinair's new AGMRI AI Agent promises instant answers to complex farm questions. Is this the tool that finally tames agricultural data for good?

Marius Silvasan's EY award highlights a deeper trend: how AI-powered fintechs are rewriting the rules of capital access for businesses of all sizes.

R1's new Phare OS intelligence engine promises to upend the slow, costly cycle of medical claims. Can real-time adjudication finally fix a broken system?

Beyond pandemic tools, this year's top innovators like Deel and Cloudbrink show remote work tech is now a core driver of global growth and security.

With its 10th acquisition and a fresh $40M, Connie Health is using its AI platform to rapidly scale and become a key partner in value-based care.

BioCardia bets its future on Japan's fast-track approval for its heart therapy, a strategic pivot that could unlock global markets or break the bank.

As fusion startup Avalanche Energy hits solar-core temperatures, its new CFO hire signals a pivotal shift from pure science to serious commercial ambition.

With Hillary Aiken leading its new philanthropic arm, 23andMe Research Institute bets on private giving to accelerate its 'public good' DNA revolution.

A new drug from Cambrian Bio shows promise in activating a key metabolic switch. This could lead to treatments that burn fat while preserving muscle mass.